Close Menu

Wellcome Sanger Institute

New Products: Aug 3, 2010



Researchers involved in the five-year Cancer Genome Project's Genomics of Drug Sensitivity study today released treatment response data on hundreds of genetically characterized cancer cell lines.

Paired Ends: Jul 13, 2010


Harold Varmus, Gerald Möller, Harold Swerdlow, Gary King

Under the project, funded primarily with $15.7 million from the Wellcome Trust, the researchers plan to sequence the complete genomes of 4,000 people from two existing studies at low coverage, and the exomes of another 6,000 individuals with severe conditions believed to have a genetic component.

The Wellcome Trust is embarking on a three-year project to sequence 4,000 whole human genomes and 6,000 exomes in an effort to better understand human disease.

New Products: May 25, 2010


Release 47 of COSMIC

Paired Ends: May 18, 2010


Harold Varmus, Mike Stratton, Bill Efcavitch, Jonathan Rothberg, Janet Davison Rowley

The institute's deputy director since 2007, Stratton is a team leader of Sanger's Cancer Genome Project, and a leader of the International Cancer Gene Consortium. He succeeds Allan Bradley, who in March stepped down after 10 years at the institute's helm.

At the Biology of Genomes meeting, 1000 Genomes Project Co-chair Richard Durbin discussed the progress of the 1000 Genomes Project and lessons learned so far.

At the Biology of Genomes meeting, Sanger Institute researcher Jeffrey Barrett argued that rare variants probably don't explain most signals detected in genome-wide association studies of common disease.


The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.

The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.

News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.

In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.